Hypodermic Needles in Hard Plastic Unit Packaging

Optimized processability

Each needle is sterile-packed individually in a hard plastic packaging (cutting a blister pack is not required).

Compact unit pack design takes up little space in secondary packaging when being by-packed.

Packaging design (rips, flanges, round shape) supports compatibility with feeders and automated pick-and-place systems.

Color-coded labels and barcode on label enable in-line product identification by a vision system.

Smooth administrations

Ergonomic design of the packaging allows a firm grip resulting in a very easy opening and removal of the cap.

Proprietary grinding process results in an exceptionally sharp lancet point able to penetrate tissue smoothly.

Homogeneously-siliconized cannula supports excellent gliding performance during administrations.

Tamper-proof labels on unit pack confirms unused state of needle.

Secure connection to syringes

Needlehub complies to ISO 80369-7, allowing a proper connection to syringes.

Go to article: Home | Improving safety for multiple drug regimes Go to article: In this issueGo to article: ContentsGo to article: Curtis Health CapsGo to article: Astrix Go to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Owen Mumford Company Insight Go to article: Owen MumfordGo to article: CommentGo to article: Use of AI in the fight against Covid-19 shows mixed results Go to article: What does Ireland’s tax hike mean for pharma?Go to article: Chinese review designations lag behind US and EUGo to article: The business benefits of text mining in life sciencesGo to article: Mettler ToledoGo to article: HOF SonderanlagenbauGo to article: In DepthGo to article: Narrow FDA panel vote on Merck’s molnupiravir bolsters outlook on mAbsGo to article: The challenges of multiple drugs safety reportingGo to article: 3D printing in drug manufacturing: unlocking future possibilitiesGo to article: Can drug repurposing uncover better treatments for UTIs?Go to article: Pfizer and Takeda deals put a spotlight on value-based pricing Go to article: Lethal injection: can pharma kill the death penalty?Go to article: Mimotopes Company Insight Go to article: MimotopesGo to article: In DataGo to article: Middle-income countries’ healthcare sectors to keep rising through to 2024Go to article: Data analytics hiring levels in clinical trial operations rose in OctoberGo to article: Industrial automation innovation in pharma rebounded in the last quarterGo to article: Global markets and indicesGo to article: Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: YearbookGo to article: SHL MedicalGo to article: Dr. Paul Lohmann Company Insight Go to article: Dr. Paul LohmannGo to article: Novo NordiskGo to article: NiproGo to article: EventsGo to article: Next issue